Literature DB >> 26931177

SHARPIN controls the development of regulatory T cells.

Vanessa Redecke1, Vandana Chaturvedi1, Jeeba Kuriakose1, Hans Häcker1.   

Abstract

SHARPIN is an essential component of the linear ubiquitin chain assembly complex (LUBAC) complex that controls signalling pathways of various receptors, including the tumour necrosis factor receptor (TNFR), Toll-like receptor (TLR) and antigen receptor, in part by synthesis of linear, non-degrading ubiquitin chains. Consistent with SHARPIN's function in different receptor pathways, the phenotype of SHARPIN-deficient mice is complex, including the development of inflammatory systemic and skin diseases, the latter of which depend on TNFR signal transduction. Given the established function of SHARPIN in primary and malignant B cells, we hypothesized that SHARPIN might also regulate T-cell receptor (TCR) signalling and thereby control T-cell biology. Here, we focus primarily on the role of SHARPIN in T cells, specifically regulatory T (Treg) cells. We found that SHARPIN-deficient (Sharpin(cpdm/cpdm) ) mice have significantly reduced numbers of FOXP3(+) Treg cells in lymphoid organs and the peripheral blood. Competitive reconstitution of irradiated mice with mixed bone marrow from wild-type and SHARPIN-deficient mice revealed an overall reduced thymus population with SHARPIN-deficient cells with almost complete loss of thymic Treg development. Consistent with this cell-intrinsic function of SHARPIN in Treg development, TCR stimulation of SHARPIN-deficient thymocytes revealed reduced activation of nuclear factor-κB and c-Jun N-terminal kinase, establishing a function of SHARPIN in TCR signalling, which may explain the defective Treg development. In turn, in vitro generation and suppressive activity of mature SHARPIN-deficient Treg cells were comparable to wild-type cells, suggesting that maturation, but not function, of SHARPIN-deficient Treg cells is impaired. Taken together, these findings show that SHARPIN controls TCR signalling and is required for efficient generation of Treg cells in vivo, whereas the inhibitory function of mature Treg cells appears to be independent of SHARPIN.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  LUBAC; SHARPIN; T-cell development; regulatory T cells; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 26931177      PMCID: PMC4863576          DOI: 10.1111/imm.12604

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  50 in total

1.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

2.  Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL-12.

Authors:  H HogenEsch; S E Torregrosa; D Boggess; B A Sundberg; J Carroll; J P Sundberg
Journal:  Eur J Immunol       Date:  2001-03       Impact factor: 5.532

3.  Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure.

Authors:  J Ruland; G S Duncan; A Elia; I del Barco Barrantes; L Nguyen; S Plyte; D G Millar; D Bouchard; A Wakeham; P S Ohashi; T W Mak
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

Review 4.  Roles of linear ubiquitinylation, a crucial regulator of NF-κB and cell death, in the immune system.

Authors:  Katsuhiro Sasaki; Kazuhiro Iwai
Journal:  Immunol Rev       Date:  2015-07       Impact factor: 12.988

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  An essential role for Scurfin in CD4+CD25+ T regulatory cells.

Authors:  Roli Khattri; Tom Cox; Sue-Ann Yasayko; Fred Ramsdell
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

7.  Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation.

Authors:  Marc Schmidt-Supprian; Jane Tian; Ethan P Grant; Manolis Pasparakis; René Maehr; Huib Ovaa; Hidde L Ploegh; Anthony J Coyle; Klaus Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-16       Impact factor: 11.205

8.  Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.

Authors:  Astrid A Ruefli-Brasse; Dorothy M French; Vishva M Dixit
Journal:  Science       Date:  2003-10-23       Impact factor: 47.728

9.  The MAGUK family protein CARD11 is essential for lymphocyte activation.

Authors:  Hiromitsu Hara; Teiji Wada; Chris Bakal; Ivona Kozieradzki; Shinobu Suzuki; Nobutaka Suzuki; Mai Nghiem; Emily K Griffiths; Connie Krawczyk; Birgit Bauer; Fulvio D'Acquisto; Sankar Ghosh; Wen Chen Yeh; Gottfried Baier; Robert Rottapel; Josef M Penninger
Journal:  Immunity       Date:  2003-06       Impact factor: 31.745

10.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

View more
  11 in total

1.  Ubiquitin-Dependent Regulation of Treg Function and Plasticity.

Authors:  Yi Dong; Fan Pan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  SHARPIN: Role in Finding NEMO and in Amyloid-Beta Clearance and Degradation (ABCD) Pathway in Alzheimer's Disease?

Authors:  Dhanya Krishnan; Ramsekhar N Menon; Srinivas Gopala
Journal:  Cell Mol Neurobiol       Date:  2021-01-05       Impact factor: 5.046

Review 3.  Met1-linked ubiquitin signalling in health and disease: inflammation, immunity, cancer, and beyond.

Authors:  Akhee Sabiha Jahan; Camilla Reiter Elbæk; Rune Busk Damgaard
Journal:  Cell Death Differ       Date:  2021-01-13       Impact factor: 12.067

4.  Distinct role of IL-1β in instigating disease in Sharpincpdm mice.

Authors:  Prajwal Gurung; Bhesh Raj Sharma; Thirumala-Devi Kanneganti
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

5.  Linear ubiquitin chain assembly complex coordinates late thymic T-cell differentiation and regulatory T-cell homeostasis.

Authors:  Charis E Teh; Najoua Lalaoui; Reema Jain; Antonia N Policheni; Melanie Heinlein; Silvia Alvarez-Diaz; Julie M Sheridan; Eva Rieser; Stefanie Deuser; Maurice Darding; Hui-Fern Koay; Yifang Hu; Fiona Kupresanin; Lorraine A O'Reilly; Dale I Godfrey; Gordon K Smyth; Philippe Bouillet; Andreas Strasser; Henning Walczak; John Silke; Daniel H D Gray
Journal:  Nat Commun       Date:  2016-11-18       Impact factor: 14.919

6.  Hepatitis B virus X protein influences enrichment profiles of H3K9me3 on promoter regions in human hepatoma cell lines.

Authors:  Di-Yi Wang; Shu-Hong An; Lei Liu; Shan-Shan Bai; Kai-Xiang Wu; Rong Zhu; Zhao-Jin Wang
Journal:  Oncotarget       Date:  2016-12-20

Review 7.  Tumour necrosis factor signalling in health and disease.

Authors:  Jonathan Holbrook; Samuel Lara-Reyna; Heledd Jarosz-Griffiths; Michael McDermott
Journal:  F1000Res       Date:  2019-01-28

8.  Modulation of autoimmune pathogenesis by T cell-triggered inflammatory cell death.

Authors:  Katsuhiro Sasaki; Ai Himeno; Tomoko Nakagawa; Yoshiteru Sasaki; Hiroshi Kiyonari; Kazuhiro Iwai
Journal:  Nat Commun       Date:  2019-08-28       Impact factor: 14.919

9.  The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity.

Authors:  Rune Busk Damgaard; Jennifer A Walker; Paola Marco-Casanova; Neil V Morgan; Hannah L Titheradge; Paul R Elliott; Duncan McHale; Eamonn R Maher; Andrew N J McKenzie; David Komander
Journal:  Cell       Date:  2016-08-11       Impact factor: 41.582

10.  SHARPIN stabilizes estrogen receptor α and promotes breast cancer cell proliferation.

Authors:  Ting Zhuang; Sifan Yu; Lichen Zhang; Huijie Yang; Xin Li; Yingxiang Hou; Zhenhua Liu; Yuanyuan Shi; Weilong Wang; Na Yu; Anqi Li; Xuefeng Li; Xiumin Li; Gang Niu; Juntao Xu; Muhammad Sharif Hasni; Kun Mu; Hui Wang; Jian Zhu
Journal:  Oncotarget       Date:  2017-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.